Figure 3.
OS and PFS of patients with MDS according to cytopenia lines and WT1/PRAME transcript levels. OS (A) and PFS (D) of patients with MDS based on cytopenia lines. OS (B) and PFS (E) of patients with MDS based on the presence and absence of WT1 high expression. OS (C) and PFS (F) of patients with MDS based on the presence and absence of PRAME high expression.